Treatment duration(months) | Number of patients | Patients with CD4 > 200 cells/μl | Patients with VL > LDL | Patients with NNRTIdr and CD4 > 200 cells/μl | Patients with NNRTIdr |
---|---|---|---|---|---|
6-18 | 184 | 156 (84.8%) | 72 (39.1%) | 34 (77.3%) | 44 |
30-42 | 148 | 114 (77.0%) | 95 (64.2%) | 43 (76.8%) | 56 |
54-67 | 200 | 147 (73.5%) | 105 (52.5%) | 49 (70.0%) | 70 |
72-102 | 182 | 143 (78.6%) | 81 (44.5%) | 56 (77.8%) | 72 |